095700 — Genexine Share News
0.000.00%
Last trade - 00:00- KR₩111bn
- KR₩200bn
- KR₩5bn
Brief: Genexine To Invest 29 Billion Won As Part Of Consortium In Building New Research And Development Centre In Seoul, South Koreａ
Brief: Genexine To Divest 19 Billion Won Worth Of Shares In Ajinomoto Genexine Co
Brief: Genexine Receives Fast Track Designation From Korean Health Authority For Vaccine For Advanced Cervical Cancer
Indonesia in talks with WHO to become global vaccine hub: minister
S.Korea's Genexine signs COVID-19 vaccine candidate manufacturing deal with Hanmi
General Atlantic to invest $55 mln in Indonesia's Kalbe Farma biotech JV
North Korea-linked hackers targeted J&J, Novavax in hunt for COVID research
Media: North Korean hackers said to have targeted cos working on Covid-19 vaccines - WSJ
S.Korea's COVID-19 test kit makers, vaccine makers fall after Pfizer vaccine report
Factbox: The race for a coronavirus vaccine
Factbox: The race for a coronavirus vaccine
S.Korea's Genexine begins human trial of coronavirus vaccine
Brief: I-Mab, Genexine Report China NMPA Clearance For Phase 2 Glioblastoma Multiforme Clinical Trial
Brief: Yuhan Corp To Export Technology Worth $870 Million To Boehringer
Brief: Genexine raises 200 bln won in private placement
Brief: Genexine lowers conversion price of 5th series convertible bonds to 49,646 won/share
Brief: Genexine entered into a clinical research collaboration with Merck & Co
Brief: Genexine granted FDA orphan drug designation for GX-H9 in growth hormone deficiency